Smithfield Trust’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-450
Closed -$13K 1119
2017
Q3
$13K Hold
450
﹤0.01% 696
2017
Q2
$14K Hold
450
﹤0.01% 687
2017
Q1
$16K Sell
450
-587
-57% -$21K ﹤0.01% 666
2016
Q4
$37K Hold
1,037
0.01% 557
2016
Q3
$36K Hold
1,037
0.01% 558
2016
Q2
$39K Hold
1,037
0.01% 531
2016
Q1
$42K Hold
1,037
0.01% 510
2015
Q4
$37K Hold
1,037
0.01% 531
2015
Q3
$33K Hold
1,037
0.01% 545
2015
Q2
$36K Hold
1,037
0.01% 561
2015
Q1
$35K Hold
1,037
0.01% 570
2014
Q4
$37K Hold
1,037
0.01% 550
2014
Q3
$33K Hold
1,037
0.01% 581
2014
Q2
$36K Hold
1,037
0.01% 576
2014
Q1
$37K Hold
1,037
0.01% 568
2013
Q4
$38K Buy
1,037
+137
+15% +$5.03K 0.01% 547
2013
Q3
$31K Hold
900
0.01% 546
2013
Q2
$30K Buy
+900
New +$29.9K 0.01% 533

Other funds holding ACH

Smithfield Trust's ACH Position: Q4 2017 in Review

Smithfield Trust sold out of Accendra Health (ACH) in Q4 2017, closing a stake of 450 shares — an estimated $13K sold.

Smithfield Trust first reported a position in ACH in Q2 2013 and held it in 18 quarters. The position peaked at $42K in Q1 2016. 230 funds tracked by Wall St. Rank hold ACH as of Q4 2017.

  • Smithfield Trust reported no remaining Accendra Health position as of Q4 2017 after selling out during the quarter.
  • Smithfield Trust sold 450 Accendra Health shares in Q4 2017, an estimated $13K.
  • Smithfield Trust first reported a position in Accendra Health in Q2 2013 and held it in 18 quarters.
  • Smithfield Trust's Accendra Health position peaked at $42K in Q1 2016.
  • 230 funds tracked by Wall St. Rank held Accendra Health as of Q4 2017.

Based on Smithfield Trust's 13F filing for Q4 2017, filed 2 Feb 2018.